1028 related articles for article (PubMed ID: 8535213)
21. [Primary central nervous system lymphoma--a report of 32 cases with literature review].
Yi JQ; Lin TY; He YJ; Huang HQ; Xia ZJ; Xia YF; Xu RH; Guo Y; Guan ZZ
Ai Zheng; 2006 Apr; 25(4):476-80. PubMed ID: 16613684
[TBL] [Abstract][Full Text] [Related]
22. Non-Hodgkin's lymphomas in Greece according to the WHO classification of lymphoid neoplasms. A retrospective analysis of 810 cases.
Economopoulos T; Papageorgiou S; Dimopoulos MA; Pavlidis N; Tsatalas C; Symeonidis A; Foudoulakis A; Pectasides D; Rontogianni D; Rizos E; Chalkia P; Anagnostopoulos A; Melachrinou M; Papageorgiou E; Fountzilas G
Acta Haematol; 2005; 113(2):97-103. PubMed ID: 15802887
[TBL] [Abstract][Full Text] [Related]
23. Clinical and prognostic relevance of the Kiel classification of non-Hodgkin lymphomas results of a prospective multicenter study by the Kiel Lymphoma Study Group.
Brittinger G; Bartels H; Common H; Dühmke E; Fülle HH; Gunzer U; Gyenes T; Heinz R; König E; Meusers P
Hematol Oncol; 1984; 2(3):269-306. PubMed ID: 6384008
[TBL] [Abstract][Full Text] [Related]
24. Changing incidence and survival in patients with aids-related non-Hodgkin's lymphomas in the era of highly active antiretroviral therapy (HAART).
Chow KU; Mitrou PS; Geduldig K; Helm EB; Hoelzer D; Brodt HR
Leuk Lymphoma; 2001 Mar; 41(1-2):105-16. PubMed ID: 11342362
[TBL] [Abstract][Full Text] [Related]
25. Non-Hodgkin's lymphoma: time trends for incidence and survival in Côte-d'Or, France.
Rolland-Portal I; Tazi MA; Milan C; Couillault C; Carli PM
Int J Epidemiol; 1997 Oct; 26(5):945-52. PubMed ID: 9363514
[TBL] [Abstract][Full Text] [Related]
26. Non-Hodgkin Lymphoma - Nodal and Extranodal: 20-Year Comparative Mortality, Survival & Biologic Behavior Analysis by Age, Sex, Race, Stage, Cell Morphology/Histology, Cohort Entry Time-Period and Disease Duration: A Systematic Review of 384,651 Total NHL Cases Including 261,144 Nodal and 123,507 Extranodal Cases for Diagnosis Years 1975-2016: (SEER*Stat 8.3.6).
Milano AF
J Insur Med; 2023 Jul; 50(1):1-35. PubMed ID: 37725503
[TBL] [Abstract][Full Text] [Related]
27. Incidence and outcomes of primary central nervous system lymphoma in solid organ transplant recipients.
Mahale P; Shiels MS; Lynch CF; Engels EA
Am J Transplant; 2018 Feb; 18(2):453-461. PubMed ID: 28805292
[TBL] [Abstract][Full Text] [Related]
28. Elderly patients with non-Hodgkin's lymphoma: population-based results in The Netherlands.
Maartense E; Hermans J; Kluin-Nelemans JC; Kluin PM; Van Deijk WA; Snijder S; Wijermans PW; Noordijk EM
Ann Oncol; 1998 Nov; 9(11):1219-27. PubMed ID: 9862053
[TBL] [Abstract][Full Text] [Related]
29. High-dose chemotherapy and autologous stem cell transplant compared with conventional chemotherapy for consolidation in newly diagnosed primary CNS lymphoma--a randomized phase III trial (MATRix).
Schorb E; Finke J; Ferreri AJ; Ihorst G; Mikesch K; Kasenda B; Fritsch K; Fricker H; Burger E; Grishina O; Valk E; Zucca E; Illerhaus G
BMC Cancer; 2016 Apr; 16():282. PubMed ID: 27098429
[TBL] [Abstract][Full Text] [Related]
30. Increasing incidence and continued dismal outcome of primary central nervous system lymphoma in Norway 1989-2003 : time trends in a 15-year national survey.
Haldorsen IS; Krossnes BK; Aarseth JH; Scheie D; Johannesen TB; Mella O; Espeland A
Cancer; 2007 Oct; 110(8):1803-14. PubMed ID: 17721992
[TBL] [Abstract][Full Text] [Related]
31. Testicular lymphoma: a population-based study of incidence, clinicopathological correlations and prognosis. The Danish Lymphoma Study Group, LYFO.
Møller MB; d'Amore F; Christensen BE
Eur J Cancer; 1994; 30A(12):1760-4. PubMed ID: 7880601
[TBL] [Abstract][Full Text] [Related]
32. [Clinical features and treatment outcomes in primary central nervous system lymphoma: a descriptive analysis of 62 patients].
Ge Y; Lin XT; Luo DL; Zhang F; Xu J; Li Z; Liu YH
Zhonghua Bing Li Xue Za Zhi; 2019 Nov; 48(11):861-866. PubMed ID: 31775435
[No Abstract] [Full Text] [Related]
33. Natural history and prognostic factors for survival in patients with acquired immune deficiency syndrome (AIDS)-related primary central nervous system lymphoma (PCNSL).
Raez LE; Patel P; Feun L; Restrepo A; Raub WA; Cassileth PA
Crit Rev Oncog; 1998; 9(3-4):199-208. PubMed ID: 10201628
[TBL] [Abstract][Full Text] [Related]
34. CB/CC diffuse lymphoma: a distinct subtype of non-Hodgkin's lymphoma? A study of 1593 patients from a Danish population-based registry. Danish LYFO Study Group.
Munksgaard L; Christensen BE; Brincker H; Pedersen NT
Ann Oncol; 1997; 8 Suppl 2():25-8. PubMed ID: 9209635
[TBL] [Abstract][Full Text] [Related]
35. A clinicopathological study of primary central nervous system lymphomas & their association with Epstein-Barr virus.
Sharma MC; Gupta RK; Kaushal S; Suri V; Sarkar C; Singh M; Kale SS; Sahoo RK; Kumar L; Raina V
Indian J Med Res; 2016 May; 143(5):605-15. PubMed ID: 27488004
[TBL] [Abstract][Full Text] [Related]
36. Clinicopathological features of extranodal lymphomas: Kuwait experience.
Temmim L; Baker H; Amanguno H; Madda JP; Sinowatz F
Oncology; 2004; 67(5-6):382-9. PubMed ID: 15713994
[TBL] [Abstract][Full Text] [Related]
37. Primary malignant lymphoma of the intestine: clinicopathologic and immunohistochemical studies of 39 cases.
Kojima M; Nakamura S; Kurabayashi Y; Shimizu K; Hosomura Y; Ohno Y; Itoh H; Yoshida K; Sano T; Sakurai S
Pathol Int; 1995 Feb; 45(2):123-30. PubMed ID: 7742924
[TBL] [Abstract][Full Text] [Related]
38. Non-Hodgkin's lymphoma in the elderly. A study of 602 patients aged 70 or older from a Danish population-based registry. The Danish LYEO-Study Group.
d'Amore F; Brincker H; Christensen BE; Thorling K; Pedersen M; Nielsen JL; Sandberg E; Pedersen NT; Sørensen E
Ann Oncol; 1992 May; 3(5):379-86. PubMed ID: 1616892
[TBL] [Abstract][Full Text] [Related]
39. Population-based Incidence and Survival for Primary Central Nervous System Lymphoma in Korea, 1999-2009.
Shin SH; Jung KW; Ha J; Lee SH; Won YJ; Yoo H
Cancer Res Treat; 2015 Oct; 47(4):569-74. PubMed ID: 25687869
[TBL] [Abstract][Full Text] [Related]
40. Evolution of the treatment of primary central nervous system lymphoma in a Regional Cancer Center of South India: Impact of high-dose methotrexate on treatment outcome.
Rudresha AH; Chaudhuri T; Lakshmaiah KC; Babu G; Lokesh KN; Rajeev LK
J Cancer Res Ther; 2020; 16(1):13-17. PubMed ID: 32362603
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
